An estimate of pediatric lives saved due to non-pharmacologic interventions during the early COVID-19 pandemic

Author:

Faust Jeremy SamuelORCID,Renton BenjaminORCID,Du Chengan,Chen Alexander Junxiang,Li Shu-Xia,Lin Zhenqiu,Krumholz HarlanORCID

Abstract

AbstractThe net effect of the pandemic mitigation strategies on childhood mortality is not known. During the first year of the COVID-19 pandemic, mitigation policies and behaviors were widespread, and although vaccinations and effective treatments were not yet widely available, the risk of death from SARS-CoV-2 infection was low. In that first year, there was a 7% decrease in medical (“natural causes”) mortality among children ages 0-9 during the first pandemic year (5% among infants <1 year and 15% among children ages 1-9) in the United States, resulting in an estimated 1,488 deaths due to medical causes averted among children ages 0-9, and 1,938 deaths averted over 24 months. The usual expected surge in winter medical deaths, particularly among children ages >1 year was absent. However, smaller increases in external (“non-natural causes”) mortality were also observed during the study period, which decreased the overall number of pediatric deaths averted during both years and the pandemic period. In total, 1,468 fewer all-cause pediatric deaths than expected occurred in the United States during the first 24 months of the COVID-19 pandemic.

Publisher

Cold Spring Harbor Laboratory

Reference6 articles.

1. CDC. 2020-2021 Flu Season Summary. Centers for Disease Control and Prevention. Published October 25, 2021. Accessed March 14, 2023. https://www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm

2. Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021

3. Mortality among Adults Ages 25-44 in the United States During the COVID-19 Pandemic

4. National Center for Health Statistics. CDC WONDER. Accessed January 16, 2023. https://wonder.cdc.gov/

5. Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3